drugset / Trial / NCT00520104
Determination of Drug Interactions of Certain Nasal Medications With Intranasal Ketamine
RandomizedCrossoverOpen-labelTreatment
Summary
This is an open label, single-center study to determine whether certain nasal medication interact with PMI-150 (intranasal ketamine) 30 mg in healthy adult volunteers and in patients with allergic rhinitis.
Timeline
- Start
- 2007-08
- Primary completion
- 2008-02
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 30 mg | Intranasal |
Indications
No indication recorded.